20-8132482-C-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015192.4(PLCB1):​c.-170C>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0432 in 354,066 control chromosomes in the GnomAD database, including 425 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.039 ( 148 hom., cov: 32)
Exomes 𝑓: 0.046 ( 277 hom. )

Consequence

PLCB1
NM_015192.4 5_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.360

Publications

0 publications found
Variant links:
Genes affected
PLCB1 (HGNC:15917): (phospholipase C beta 1) The protein encoded by this gene catalyzes the formation of inositol 1,4,5-trisphosphate and diacylglycerol from phosphatidylinositol 4,5-bisphosphate. This reaction uses calcium as a cofactor and plays an important role in the intracellular transduction of many extracellular signals. This gene is activated by two G-protein alpha subunits, alpha-q and alpha-11. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
PLCB1 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 12
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 20-8132482-C-A is Benign according to our data. Variant chr20-8132482-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 897294.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0751 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLCB1NM_015192.4 linkc.-170C>A 5_prime_UTR_variant Exon 1 of 32 ENST00000338037.11 NP_056007.1 Q9NQ66-1
PLCB1NM_182734.3 linkc.-170C>A 5_prime_UTR_variant Exon 1 of 33 NP_877398.1 Q9NQ66-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLCB1ENST00000338037.11 linkc.-170C>A 5_prime_UTR_variant Exon 1 of 32 1 NM_015192.4 ENSP00000338185.6 Q9NQ66-1

Frequencies

GnomAD3 genomes
AF:
0.0395
AC:
5982
AN:
151564
Hom.:
149
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0325
Gnomad AMI
AF:
0.0450
Gnomad AMR
AF:
0.0487
Gnomad ASJ
AF:
0.0891
Gnomad EAS
AF:
0.000393
Gnomad SAS
AF:
0.0216
Gnomad FIN
AF:
0.0175
Gnomad MID
AF:
0.0994
Gnomad NFE
AF:
0.0460
Gnomad OTH
AF:
0.0505
GnomAD4 exome
AF:
0.0460
AC:
9320
AN:
202392
Hom.:
277
Cov.:
3
AF XY:
0.0472
AC XY:
4917
AN XY:
104156
show subpopulations
African (AFR)
AF:
0.0347
AC:
176
AN:
5070
American (AMR)
AF:
0.0504
AC:
276
AN:
5472
Ashkenazi Jewish (ASJ)
AF:
0.109
AC:
725
AN:
6652
East Asian (EAS)
AF:
0.00
AC:
0
AN:
17430
South Asian (SAS)
AF:
0.0294
AC:
78
AN:
2650
European-Finnish (FIN)
AF:
0.0249
AC:
540
AN:
21712
Middle Eastern (MID)
AF:
0.0902
AC:
90
AN:
998
European-Non Finnish (NFE)
AF:
0.0522
AC:
6784
AN:
130008
Other (OTH)
AF:
0.0525
AC:
651
AN:
12400
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.535
Heterozygous variant carriers
0
406
812
1219
1625
2031
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0394
AC:
5982
AN:
151674
Hom.:
148
Cov.:
32
AF XY:
0.0381
AC XY:
2828
AN XY:
74130
show subpopulations
African (AFR)
AF:
0.0326
AC:
1349
AN:
41408
American (AMR)
AF:
0.0485
AC:
740
AN:
15250
Ashkenazi Jewish (ASJ)
AF:
0.0891
AC:
309
AN:
3468
East Asian (EAS)
AF:
0.000394
AC:
2
AN:
5070
South Asian (SAS)
AF:
0.0214
AC:
103
AN:
4816
European-Finnish (FIN)
AF:
0.0175
AC:
185
AN:
10550
Middle Eastern (MID)
AF:
0.103
AC:
30
AN:
290
European-Non Finnish (NFE)
AF:
0.0460
AC:
3119
AN:
67810
Other (OTH)
AF:
0.0495
AC:
104
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
290
580
869
1159
1449
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0423
Hom.:
14
Bravo
AF:
0.0417
Asia WGS
AF:
0.0140
AC:
49
AN:
3446

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 01, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Developmental and epileptic encephalopathy, 12 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
CADD
Benign
10
DANN
Benign
0.88
PhyloP100
0.36
PromoterAI
-0.059
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.0
Mutation Taster
=299/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139962835; hg19: chr20-8113129; API